A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)
Public ClinicalTrials.gov record NCT07128615. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I/II, Double-blinded, Randomized, Placebo-Controlled, Dose Selection Study in Adults to Assess the Safety and Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and immunogenicity of two investigational vaccines, AZD4117 and AZD5315 to protect against certain strains of avian Influenza A (H5N1 and H7N9 subtypes).
Study identification
- NCT ID
- NCT07128615
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 405 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 4, 2025 (Actual)
- Primary completion
- Jan 28, 2026 (Actual)
- Completion
- Dec 29, 2026 (Estimated)
- Last update posted
- Oct 9, 2026
2025 – 2026
United States locations
- U.S. sites
- 14
- U.S. states
- 13
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Long Beach | California | 90815 | — |
| Research Site | Rolling Hills Estates | California | 90274 | — |
| Research Site | Miami Lakes | Florida | 33016 | — |
| Research Site | Stockbridge | Georgia | 30281 | — |
| Research Site | Chicago | Illinois | 60640 | — |
| Research Site | Lenexa | Kansas | 66219 | — |
| Research Site | Kansas City | Missouri | 64114 | — |
| Research Site | Omaha | Nebraska | 68134 | — |
| Research Site | Las Vegas | Nevada | 89119 | — |
| Research Site | Cincinnati | Ohio | 45212 | — |
| Research Site | Edmond | Oklahoma | 73013 | — |
| Research Site | North Charleston | South Carolina | 29405 | — |
| Research Site | Austin | Texas | 78745 | — |
| Research Site | West Jordan | Utah | 84088 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07128615, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 9, 2026 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07128615 live on ClinicalTrials.gov.